| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.305 | 29.959 | 49.225 | 74.774 | 77.474 | 105.866 | 158.722 | 279.979 | 300.732 |
| Total Income - EUR | - | 1.305 | 29.959 | 49.225 | 74.774 | 77.474 | 105.866 | 158.722 | 279.986 | 300.732 |
| Total Expenses - EUR | - | 610 | 4.350 | 4.929 | 8.438 | 14.691 | 14.808 | 13.231 | 18.746 | 30.244 |
| Gross Profit/Loss - EUR | - | 695 | 25.610 | 44.296 | 66.335 | 62.783 | 91.058 | 145.490 | 261.239 | 270.488 |
| Net Profit/Loss - EUR | - | 656 | 24.710 | 42.820 | 64.092 | 60.593 | 87.945 | 142.133 | 258.440 | 261.465 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Oncoing Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 175 | 0 | 0 | 0 | 3.749 | 439 | 346 | 22.216 | 18.020 |
| Current Assets | - | 1.076 | 26.719 | 43.698 | 64.842 | 57.880 | 90.627 | 162.929 | 264.846 | 251.539 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 619 | 1.984 |
| Receivables | - | 0 | 17.953 | 11.994 | 40.366 | 26.905 | 43.288 | 98.899 | 68.130 | 158.686 |
| Cash | - | 1.076 | 8.766 | 31.705 | 24.476 | 30.975 | 47.338 | 64.030 | 196.097 | 90.868 |
| Shareholders Funds | - | 701 | 25.398 | 42.871 | 64.143 | 60.642 | 87.994 | 142.181 | 258.488 | 261.514 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 551 | 1.321 | 827 | 699 | 986 | 3.072 | 21.094 | 28.574 | 8.045 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncoing Medical Srl